Trial Report Advancing Therapeutics for Post-Viral ME/CFS and SFN in Long COVID: A 20- Week Sensomotoric Training Intervention, 2023, Ziaja et al

Mij

Senior Member (Voting Rights)
Advancing Therapeutics for Post-Viral ME/CFS and SFN in Long COVID: A 20- Week Sensomotoric Training Intervention

Long COVID's (LC) emergence drives research and novel treatments for myalgic encefalitis ME/CFS. Sensomotoric-training's potential to regenerate ectodermal fibers offers hope for SFN patients. Research Focus: Long COVID's surge prompts innovative ME/CFS treatments targeting underlying causes. Sensomotoric-training's fiber regrowth potential could transform SFN management. Conclusion: Rising ME/CFS cases from Long COVID fuel research and therapeutic progress. Sensomotoric-training holds promise for SFN treatment. Exciting developments shape patient care.

https://www.researchgate.net/public...Id=64db59b9ad846e288293e51c&showFulltext=true
 
Last edited by a moderator:
Advancing Therapeutics for Post-Viral ME/CFS and SFN in Long COVID: A 20- Week Sensomotoric Training Intervention

Long COVID's (LC) emergence drives research and novel treatments for myalgic encefalitis ME/CFS. Sensomotoric-training's potential to regenerate ectodermal fibers offers hope for SFN patients. Research Focus: Long COVID's surge prompts innovative ME/CFS treatments targeting underlying causes. Sensomotoric-training's fiber regrowth potential could transform SFN management. Conclusion: Rising ME/CFS cases from Long COVID fuel research and therapeutic progress. Sensomotoric-training holds promise for SFN treatment. Exciting developments shape patient care.

https://www.researchgate.net/public...Id=64db59b9ad846e288293e51c&showFulltext=true
SFN is apparently Small Fiber Neuropathy (from downloaded PDF of the study).
 
Last edited by a moderator:
Back
Top Bottom